Voxtalisib, also known as XL-765 and SAR245409, is a PI3K/mTOR dual kinase inhibitor XL765 is an orally bioavailable small molecule targeting the phosphatidylinositol 3 kinase (PI3K) and mammalian target of rapamycin (mTOR) kinases in the PI3K/mTOR signaling pathway, with potential antineoplastic activity. PI3K/mTOR dual kinase inhibitor XL765 inhibits both PI3K kinase and mTOR kinase, which may result in tumor cell apoptosis and growth inhibition in susceptible tumor cell populations. Activation of the PI3K/mTOR pathway promotes cell growth, survival, and resistance to chemotherapy and radiotherapy; mTOR, a serine/threonine kinase downstream of PI3K, may also be activated in a PI3K-independent fashion in response to nutrient and energy deprivation. Accordingly, this agent maybe more potent compared to an agent that inhibits either PI3K kinase or mTOR kinase alone.

June 21, 2017

prudect name : Voxtalisib, also known as XL-765 and SAR245409, is a PI3K/mTOR dual kinase inhibitor XL765 is an orally bioavailable small molecule targeting the phosphatidylinositol 3 kinase (PI3K) and…

๐Ÿ“Œ
0๐Ÿ’ฌ read more

prudect name : VilazodoneSynonyms: CAS NO: 163521-12-8Molecular Formula: C26H27N5O2Molecular Weight: 441.52Purity: 98% minSolubility: In DMSOStorage:

prudect name : Vilazodone Synonyms: CAS NO: 163521-12-8Molecular Formula: C26H27N5O2Molecular Weight: 441.52Purity: 98% minSolubility: In DMSOStorage: -20°C web site: www.medchemexpress.com

๐Ÿ“Œ
0๐Ÿ’ฌ read more

GS-9451 is a potent macrocyclic HCV NS3 PI that achieved a median maximal change in HCV RNA of 3.6 log10 IU/mL (range, -4.7 log10 to -3.1 log10 IU/mL) following 3-day monotherapy in treatment-naïve patients with HCV genotype 1 infection during phase I. In multiple GT1a and GT1b replicon cell lines, GS-9451 had mean 50% effective concentrations (EC50s) of 13 and 5.4 nM, respectively, with minimal cytotoxicity; similar potency was observed in chimeric replicons encoding the NS3 protease gene of GT1 clinical isolates. GS-9451 was less active in GT2a replicon cells (EC50 = 316 nM). GS-9451 showed good oral bioavailability in all three species tested.

prudect name : GS-9451 is a potent macrocyclic HCV NS3 PI that achieved a median maximal change in HCV RNA of 3.6 log10 IU/mL (range, -4.7 log10 to -3.1 log10…

๐Ÿ“Œ
0๐Ÿ’ฌ read more

VU 0361737 is a selective positive allosteric modulator (PAM) for mGlu4 receptor with EC50 of 240 nM and 110 nM at human and rat receptors, respectively, displays weak activity at mGlu5 and mGlu8 receptors, is inactive at mGlu1, mGlu2, mGlu3, mGlu6 and mGlu7 receptors, can penetrate into CNS.

prudect name : VU 0361737 is a selective positive allosteric modulator (PAM) for mGlu4 receptor with EC50 of 240 nM and 110 nM at human and rat receptors, respectively, displays…

๐Ÿ“Œ
0๐Ÿ’ฌ read more

prudect name : Vancomycin hydrochlorideSynonyms: CAS NO: 1404-93-9Molecular Formula: C66H75Cl2N9O24.HClMolecular Weight: 1485.72Purity: 98% minSolubility: Storage:

prudect name : Vancomycin hydrochloride Synonyms: CAS NO: 1404-93-9Molecular Formula: C66H75Cl2N9O24.HClMolecular Weight: 1485.72Purity: 98% minSolubility: Storage: -20°C web site: www.medchemexpress.com

๐Ÿ“Œ
0๐Ÿ’ฌ read more

VTP-27999 Hcl is an alkyl amine Renin inhibitor; VTP-27999 is useful for Hypertension and End-Organ Diseases.

prudect name : VTP-27999 Hcl is an alkyl amine Renin inhibitor; VTP-27999 is useful for Hypertension and End-Organ Diseases.VTP27999 HCL Synonyms: CAS NO: 1264191-73-2Molecular Formula: C26H41ClN4O5.HClMolecular Weight: 561.54Purity: 98% minSolubility:…

๐Ÿ“Œ
0๐Ÿ’ฌ read more

Valganciclovir (hydrochloride), the L-valyl ester of ganciclovir, is actually a prodrug for ganciclovir. Valganciclovir is an antiviral medication used to treat cytomegalovirus infections.

prudect name : Valganciclovir (hydrochloride), the L-valyl ester of ganciclovir, is actually a prodrug for ganciclovir. Valganciclovir is an antiviral medication used to treat cytomegalovirus infections.Valganciclovir hydrochloride Synonyms: CAS NO:…

๐Ÿ“Œ
0๐Ÿ’ฌ read more

Biological Activity of ABT-888(Veliparib): ABT-888 is a potent inhibitor of both PARP-1 and PARP-2 by [3H]NAD+ with Kis of 5.2 and 2.9 nmol/L, respectively.The compound has good oral bioavailability and crosses the blood-brain barrier. ABT-888 strongly potentiated temozolomide in the B16F10 s.c. murine melanoma model. In the MX-1 breast xenograft model(BRCA1 deletion and BRCA2 mutation), ABT-888 potentiated cisplatin, carboplatin, and cyclophosphamide,causing regression of established tumors, whereas with comparable doses of cytotoxic agents alone, only modest tumor inhibition was exhibited

prudect name : Biological Activity of ABT-888(Veliparib): ABT-888 is a potent inhibitor of both PARP-1 and PARP-2 by [3H]NAD+ with Kis of 5.2 and 2.9 nmol/L, respectively.The compound has good…

๐Ÿ“Œ
0๐Ÿ’ฌ read more

Voriconazole (VFEND) is a triazole antifungal medication that is generally used to treat serious, invasive fungal infections. These are generally seen in patients who are immunocompromised, and include invasive candidiasis, invasive aspergillosis, and certain emerging fungal infections.

prudect name : Voriconazole (VFEND) is a triazole antifungal medication that is generally used to treat serious, invasive fungal infections. These are generally seen in patients who are immunocompromised, and…

๐Ÿ“Œ
0๐Ÿ’ฌ read more

Vidofludimus(4SC-101; SC12267) is a novel immunosuppressive drug that inhibits DHODH; inhibits IL-17 secretion in vitro independently of effects on lymphocyte proliferation.

prudect name : Vidofludimus(4SC-101; SC12267) is a novel immunosuppressive drug that inhibits DHODH; inhibits IL-17 secretion in vitro independently of effects on lymphocyte proliferation.Vidofludimus(4SC-101; SC12267) Synonyms: CAS NO: 717824-30-1Molecular Formula:…

๐Ÿ“Œ
0๐Ÿ’ฌ read more